Nexus Pharmaceuticals is releasing methylene blue injection. Methylene blue injection is indicated for the treatment of methemoglobinemia—a condition that affects the blood’s ability to carry oxygen. ...
Methylene blue injection, 50mg/10ml had a market value of approximately $36 million in the 12 months ending April 2025, per IQVIA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback